tiprankstipranks
Trending News
More News >

Ansbert Gadicke Insider Profile

4 Followers
Ansbert Gadicke, Director at Chiasma, holds ― shares in Chiasma (Ticker: CHMA), holds 3.45M shares in iTeos Therapeutics (Ticker: ITOS), holds 6.72M shares in Werewolf Therapeutics (Ticker: HOWL). Most recently, Ansbert Gadicke ― shares of Chiasma on ― for an estimated value of ―.
tipranks
Ansbert Gadicke

Ansbert Gadicke
Chiasma (CHMA)
Director

Ranked #29,390 out of 102,830 Corporate Insiders

Profitable Transactions

50%
6 out of 12 Profitable Transactions

Average Return

+3.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$155M
40.08%
28.42%
22.50%
5.15%
3.84% Others
A breakdown of Ansbert Gadicke's holdings

Insider Roles

Cullinan Management
(CGEM)
Director
Kalaris Therapeutics
(KLRS)
Director, Ten Percent Owner
iTeos Therapeutics
(ITOS)
Former 10% Owner
Werewolf Therapeutics
(HOWL)
Ten Percent Owner
+2 other positions
Roles that Ansbert Gadicke holds in companies

Most Profitable Insider Trade

Stock:
Repare Therapeutics
(RPTX)
Rating:Informative Sell
Date:Mar 15, 2021 - Mar 15, 2022
Return:+57.20%
The most profitable trade made by Ansbert Gadicke

Ansbert Gadicke's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
CHMA
Chiasma
HARP
Harpoon Therapeutics
Jun 02, 2021
Uninformative Sell
1.19M
$145.61M
TCRR
TCR2 Therapeutics
Jun 05, 2023
Uninformative Sell
$0.00
Repare Therapeutics
Jul 13, 2021
Ten Percent Owner
Uninformative Sell
2.08M
$5.94M
iTeos Therapeutics
May 15, 2025
Former 10% Owner
Informative Sell
8.32M
$34.91M
Kalaris Therapeutics
Aug 01, 2022
Director, Ten Percent Owner
Uninformative Buy
15.00M
$44.10M
ONCR
Oncorus
Oct 08, 2020
Informative Buy
4.88M
$299.51K
Cullinan Management
Sep 20, 2021
Director
Uninformative Sell
103.34K
$62.20M
Werewolf Therapeutics
Apr 30, 2025
Ten Percent Owner
Uninformative Sell
4.61K
$8.00M
PETX
Aratana
Mar 10, 2014
Informative Sell
538.53K
$16.67M
~RSLS
ReShape Lifesciences
Feb 25, 2009
Informative Buy
2.03M
$10.69M
Verastem
Feb 03, 2012
Director
Uninformative Buy
$21.39K
IDIX
Idenix Pharma
~RDUS
Radius Health
Sep 29, 2016
Uninformative Sell
$21.59M
List of latest transactions for each holding click on a transaction to see Ansbert Gadicke's performance on stock

Ansbert Gadicke insider profile FAQ

What is the percentage of profitable transactions made by Ansbert Gadicke?
The percentage of profitable transactions made by Ansbert Gadicke is 50%.
    What is the average return per transaction made by Ansbert Gadicke?
    The average return per transaction made by Ansbert Gadicke is 3.10%.
      What stocks does Ansbert Gadicke hold?
      Ansbert Gadicke holds: CHMA, HARP, TCRR, RPTX, ITOS, KLRS, ONCR, CGEM, HOWL, PETX, ~RSLS, VSTM, IDIX, ~RDUS stocks.
        What was Ansbert Gadicke’s latest transaction?
        Ansbert Gadicke latest transaction was an Uninformative Buy of ―.
          What was Ansbert Gadicke's most profitable transaction?
          Ansbert Gadicke’s most profitable transaction was an Informative Sell of RPTX stock on March 15, 2021. The return on the trade was 57.20%.
            What is Ansbert Gadicke's role in Chiasma?
            Ansbert Gadicke's role in Chiasma is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.